FNLC vs SSSS

FNLC presents a compelling value opportunity, trading significantly below its Graham Number ($41.20) and Intrinsic Value ($88.21). While the Piotroski F-Score of 4/9 indicates stable but not strong financial health, the company exhibits robust growth with YoY earnings increasing by 41.10%. The 5% dividend yield is well-supported by a sustainable payout ratio of 59.61%. Despite a severely bearish technical trend, the fundamental valuation and growth metrics suggest a strong margin of safety.

SuRo Capital Corp. presents a stark divergence between price momentum and fundamental health. While the stock has seen an extraordinary 1-year return of 214%, the deterministic health indicators are weak, highlighted by a Piotroski F-Score of 3/9. The company is experiencing a severe collapse in revenue growth (-54.4% YoY and -491.4% Q/Q) and deeply negative operating margins, despite a low trailing P/E. The valuation remains supported by the Graham Number ($18.0), but the negative forward P/E suggests a deteriorating earnings outlook.